Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Glycitein has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Soy delivers this isoflavone almost entirely as glucoside and malonylglucoside conjugates that absorb poorly intact. Bacterial beta-glucosidases cleave the sugar and release the absorbable aglycone in the gut. Two people eating identical soy can end up with markedly different circulating levels because of this step alone.
Selected Lactobacillus strains are used industrially to pre-convert soy isoflavone glucosides to aglycones during fermentation, which is why fermented soy foods carry a higher aglycone share. Co-formulating shifts the delivered form. Enzyme activity is strain-specific and not a property of the genus as a whole.
Fermentable fibre feeds the colonic bacteria responsible for isoflavone deconjugation and onward metabolism. Shifting the community shifts what is liberated and absorbed. The direction is well supported for isoflavones generally, and the magnitude in people has not been settled.
This compound is the 6-methoxy derivative of daidzein, so the two are structurally adjacent and appear together in every soy extract. They share the same absorption and conjugation routes. The methoxy group is what differentiates the pharmacokinetics of the two.
Ascorbate can regenerate oxidised phenolic species in solution, and isoflavone phenols sit in that chemistry. This has been characterised in vitro rather than in people. It is a mechanism worth stating and not a demonstrated combined benefit.
MK-7 comes from Bacillus subtilis fermentation of soybeans, so both constituents already coexist in natto. They act by unrelated routes, K2 through gamma-carboxylation of bone matrix proteins. The pairing is compositional convention rather than a measured interaction.
Soy isoflavone material is routinely bundled with calcium and vitamin D in bone-support products. Calcium has not been shown to alter isoflavone absorption in either direction. This is formulation practice.
Vitamin D and soy isoflavones are frequently combined in products aimed at bone mineral support in midlife women. The two act through entirely separate routes and no absorption interaction has been reported. Read the pairing as product design.
Nothing specific on file for Glycitein. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 4 we read for Glycitein. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.